|CBU Currency of 19.02.2019|
|www.cbu.uz||USD = 8392.2|
|EUR = 9477.31|
|RUB = 126.25|
The Agency for Development of Pharmaceutical Industry under the Ministry of Health of Uzbekistan reached agreements on organizing production of Korean high-performance drugs in Uzbekistan.
The agreements were reached within the framework of the state visit of the President of the Republic of Uzbekistan Shavkat Mirziyoyev to the Republic of Korea,
According to the press center for coverage of the state visit of the President of Uzbekistan to the Republic of Korea, the Agency for Development of Pharmaceutical Industry reached agreements with such leading Korean companies as Dalim BioTech, Yuhan Corporation and Erae.
As part of the reached agreements, Korean companies will invest US$25.0 million foreign direct investment into Uzbekistan.
The sides agreed on accelerating implementation of investment projects. Particular attention was paid to the creation in the Republic of Uzbekistan of 7 new pharmaceutical free economic zones.
The Korean companies have assured their firm intention to cooperate and invest in Uzbekistan.
Uzbekistan creates Ministry of Transport08 February 2019
Tashkent plant for construction and repair of passenger cars modernized metro cars08 January 2019
President abolishes Fund to promote price stabilization in consumer market08 January 2019
The Ministry of Finance publishes a list of food products, exempted from VAT08 January 2019
Concept of development of transport complex of Tashkent city discussed08 January 2019
A new airport to be opened in Tashkent in 2020